Home NDC 70510-2171-2 RADICAVA
Product NDC 70510-2171
Requested package NDC 70510-2171-2
11-digit product format 705102171
Labeler code 70510
Product ID 70510-2171_5568c252-2a53-4307-8961-063865500fc6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name EDARAVONE
Dosage form INJECTION
Route INTRAVENOUS
Labeler Mitsubishi Tanabe Pharma America, Inc.
Application NDA209176
Marketing category NDA
Marketing start 2017-05-05
Marketing end 0000-00-00
Substance EDARAVONE
Active strength 30 mg/100mL
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209176-001 RADICAVA EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD 2017-05-05 N209176-002 RADICAVA EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS RLD 2018-11-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD 2017-05-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS RLD 2018-11-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD 2017-05-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD 2018-11-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD 2017-05-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD 2018-11-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2017-05-05 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2018-11-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-05-05 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2018-11-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-05-05 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2018-11-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-05-05 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2018-11-15 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-05-05 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2018-11-15 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209176-001 RADICAVA 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-05-05 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N209176-002 RADICAVA 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2018-11-15 bb7c543d1eb4…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N209176-001 6933310 2020-11-13 U-2013 2017-05-31 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N209176-002 6933310 2020-11-13 U-2013 2018-12-04 74a2ff9319b5…2020-12-22 03:56 UTC 2020-12 N209176-001 6933310 2020-11-13 U-2013 2017-05-31 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N209176-002 6933310 2020-11-13 U-2013 2018-12-04 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N209176-001 6933310 2020-11-13 U-2013 2017-05-31 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N209176-002 6933310 2020-11-13 U-2013 2018-12-04 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N209176-001 6933310 2020-11-13 U-2013 2017-05-31 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N209176-002 6933310 2020-11-13 U-2013 2018-12-04 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N209176-001 6933310 2020-11-13 U-2013 2017-05-31 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N209176-002 6933310 2020-11-13 U-2013 2018-12-04 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N209176-001 6933310 2020-11-13 U-2013 2017-05-31 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N209176-002 6933310 2020-11-13 U-2013 2018-12-04 ea99ee380514…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 95 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70510-2171-1 RADICAVA 100 mL in 1 BAG INJECTION 100 29 70510-2171-2 RADICAVA 2 in 1 CARTON INJECTION 2 29
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70510-2171 RADICAVA (EDARAVONE) INJECTION RADICAVA ORS (EDARAVONE) KIT [MITSUBISHI TANABE PHARMA AMERICA, INC.] 24 Legacy NDC, 2 package rows 20250305_0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70510-2171-2 70510217102 2 BAG in 1 CARTON (70510-2171-2) > 100 mL in 1 BAG (70510-2171-1) 2 bag 2017-05-05 0000-00-00 No No Current